The novel approach of tirzepatide peptide represents a significant breakthrough in the care of diabetes mellitus type 2. Different to existing therapies, tirzepatide impacts two pathways – the GLP-1 hormone and GIP – providing improved glucose control and anticipated reduction in weight. Research